Ten type 1 diabetic patients recorded their daily home blood glucose values, pre-and post-prandially, for 12 weeks. Blood was collected weekly for HbA 1e and total haemoglobin measurement. A rolling 28-day mean of all blood glucose values and a glycation index (the ratio of the HbA 1e to the rolling mean blood glucose) were calculated. In the pooled patients' data, there was a large scatter of results about the HbA le versus mean blood glucose regression line. There was less variation in the results of individual patients. The glycation indices showed marked inter-individual variation, and in 60% of patients there was an inverse relationship between glycation index and mean blood glucose, suggesting a non-linear relationship between mean blood glucose and HbA 1e. Patients should be monitored on the basis of their own previous results, and in some patients blood HbA le may be a less sensitive index of mean blood glucose concentration at higher glucose levels.
SUMMARY. Ten type 1 diabetic patients recorded their daily home blood glucose values, pre-and post-prandially, for 12 weeks. Blood was collected weekly for HbA 1e and total haemoglobin measurement. A rolling 28-day mean of all blood glucose values and a glycation index (the ratio of the HbA 1e to the rolling mean blood glucose) were calculated. In the pooled patients' data, there was a large scatter of results about the HbA le versus mean blood glucose regression line. There was less variation in the results of individual patients. The glycation indices showed marked inter-individual variation, and in 60% of patients there was an inverse relationship between glycation index and mean blood glucose, suggesting a non-linear relationship between mean blood glucose and HbA 1e. Patients should be monitored on the basis of their own previous results, and in some patients blood HbA le may be a less sensitive index of mean blood glucose concentration at higher glucose levels.
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Blood haemoglobin Ale (HbA Ic ) measurements are routinely used in diabetes mellitus to assess glycaemic control retrospectively. In the mid 1970s it became clear that HbA 1 resulted from a posttranslational modification of HbA by glucose and that there was a relationship between HbA I and mean fasting glucose, mean daily glucose, highest daily glucose and the physician's rating of control.l-? HbA le is considered useful for assessing long-term control and, nowadays, with its ready availability to the clinician, may form the basis of adjustments in therapy. It has also become increasingly recognized, as a result of the Diabetes Control and Complications TriaI,3 as a risk factor for the development of tissue complications.
Studies on the biological variation of Hb/r., in diabetic subjects have, however, drawn attention to the difficulties in interpreting results due to within-and between-subject variation." In this study, we have investigated the relationship between mean blood glucose and HbAj, in type 1 diabetes. In particular, we have looked at the Correspondence: Mr P R Hudson. E-mail: peter.hudson(a)new-tr.wales.nhs,uk sources of variation in this relationship and its impact on the management of individual patients.
PATIENTS AND METHODS
The study was conducted with local ethical committee approval. Ten type 1 diabetic patients were recruited: six women and four men. The patients were chosen randomly from those attending the diabetic clinic on the basis of their availability to undertake the study, which lasted a total of 12 weeks. Patients were asked to measure their own capillary blood glucose values (Accutrend Glucose Meter, Boehringer Mannheim UK, Lewes, UK) twice a day for the period of the study. They were all experienced users of the meter and had been trained according to the recommendations of the manufacturer. Further training was carried out by an experienced diabetes liaison nurse prior to the study. In order to avoid errors in the mean blood glucose calculation caused by missed peak glucose values, samples were collected before and after breakfast, lunch, tea and supper over a 4-day consecutive cycle. The patients attended every week to have blood collected for HbA 1e (Glycomat 765, Chiron Diagnostics Ltd, Halstead, UK), total haemoglobin and white cell count (Coulter STKS, Coulter Electronics Ltd, Luton, UK) and routine biochemical tests (Synchron CX7, Beckman Instruments (UK) Ltd, High Wycombe, UK). On their first visit to clinic, blood was collected for the measurement of HbF s and ferritin (ACS 180, Chiron Diagnostics Ltd, Halstead, UK).
Patients recorded an average of 84 pre-prandial blood glucoses, 75 post-prandial glucoses and had 13 weekly blood HbA l c measurements.
A rolling 28-day mean of all blood glucoses was calculated. In addition, a 'glycation index" was calculated as the ratio of the % HbA l c to the 28-day mean blood glucose. This expressed the degree of glycation of haemoglobin per mmol/L of blood glucose.
Statistical calculations were performed using Statistica for Windows (StatSoft, Inc, Tulsa OK, USA). Descriptive statistics were calculated using the Basic Statistics module. None of the continuous variables were log-normally distributed (Kolmogorov-Smirnov test), so were applied untransformed. Inter-and intra-individual components of variance were calculated by analysis of variance (ANOVA) using the ANOVAI MANOVA module. Scheffe post-hoc testing was used for multiple comparisons between groups. As the data comprised repeated analyses of HhAj, and blood glucose within individuals, the Variance Components and Mixed Model ANOVA/nested analysis of covariance (ANCOVA) module was used to measure the effect of various factors on HbA lc ' For this purpose, an ANCOVA model was used, with the factors 'replicate number' ('within-patient') and 'patient number' ('between-patients') nested one within the other. This model allowed the testing of the effect of covariates such as mean blood glucose, glycation index, duration of diabetes and total blood haemoglobin on the blood HbA lc ' Tables I and 2 . These are expressed either as overall means, with number of observations and standard deviation in parentheses, or (in the case of HbF and ferritin) as the result of a single analysis.
RESULTS

Individual patients' results are summarized in
Blood HbA lc values were measured by means of cation-exchange high-performance liquid chromatography. Because the presence of HbF and carbamyl haemoglobin are both known to interfere with this method," patients' blood HbF and urea were confirmed to be normal at the start of the study.
Inter-and intra-individual components of variance for the HbA l c results were calculated using standard methods.! Analytical variance of the HbA lc assay was calculated from betweenbatch replicates of control material. This was subtracted from the inter-and intra-individual variances calculated from the patients' weekly .. levels for similar blood glucose values. A glycation index was therefore calculated as the ratio of the HbA lc to the mean blood glucose. This was an expression of the % HbA lc value for each mmol/L of blood glucose. One-way ANOVA of the patients' glycation indices showed a significant difference between patients (£9,82=10,18, P<O·OOOl). Scheffe post-hoc testing confirmed multiple differences between individual patients ( Fig. 3 ). To support these observations, the nested ANCOVA was repeated with glycation index as the dependent variable in place of HbA 1c (see Table 4 ). This analysis also showed significant differences between patients. In addition, it showed that the blood glucose had a highly significant effect on the glycation index and that the glycation index increased with duration of disease. Regression analysis indicated that, in all but four patients (patients 6-9),
HbA 1c values. Expressed as coefficients of variation, analytical, intra-and inter-individual components of variance were 3·4%, 6·31% and 10·19%, respectively. The Index ofIndividuality (101), calculated as the intra-individual CV to inter-individual CV ratio, was 0·62.
A scatter diagram of all HbA1c/mean blood glucose pairs is shown in Fig. 1 , together with a regression line and 95% confidence ellipse. It is evident from the confidence ellipse that an HbA 1c value of 9'0%, for example, was associated with blood glucose values of between 7·8 and 13·9mmol/L. Conversely, a blood glucose of 10mmol/L was associated with HbA 1c values of between 6·22% and 10·82%. For the purpose of comparison with previously published work, the correlation coefficient was calculated to be 0·23 (95% confidence interval 0,025--0-414).
When individual patients' graphs were plotted (Fig. 2) , they appeared to follow more closely their respective regression lines, although in only one case was the slope of the regression line significantly different from zero [patient 7: HbA 1c=-1'75+0'84 (SE 0'27)xmean blood glucose, P=0·017].
To examine other factors likely to influence the blood HbA lc values, the variables total haemoglobin, duration of the disease and the mean blood glucose were included as covariates in a nested ANCOVA model, with 'patient number' and 'replicate number' as factors. The results (see Table 3 ) confirm the significant interindividual differences in blood HbA 1c, the weak relationship between mean blood glucose and HbA 1c, and also indicate that HbA lc values rise with increasing duration of disease.
It was noted (Fig. 2 ) that individual patients' HbA lc values appeared to be set at different there was a significant decline in glycation index with increasing 28-day mean blood glucose ( Fig. 4) , as shown by their regression coefficients being significantly different from zero (P < 0,05).
DISCUSSION
The present study illustrates the problems in using reference ranges derived from population studies to interpret individual HbA 1c values. The values for intra-and inter-individual variation calculated from the data were broadly in agreement with previously published values." The calculated 101 of 0·62 is close to the figure of 0,6, below which inter-individual variation will be so great that reference intervals derived from population studies will be of limited use in interpreting individual tests.!" The graphical presentation of individual patients' results ( Fig. 2 ) bears out the statistical treatment, in that there appears to be far less variation about individual regression lines.
It is a conventional assumption that, in diabetes, blood HbA 1c values reflect the patient's mean blood glucose values over the preceding 3~months. I I However, statistically significant correlations have been observed between blood HbA 1c levels and mean blood glucose levels over periods as short as I week prior to HbA 1c measurement. 12 Using computermodelling techniques validated against in vivo studies of diabetic patients, it has been shown that the HbA\c fraction corresponds to an exponentially weighted average of daily mean blood glucose levels over the preceding 4 weeks.'? In this present study, therefore, patients' mean blood glucose values were calculated for the 28 days prior to each blood HbA 1c estimation. Although it was not the purpose of this study to Ann elin Biochem 1999: 36 test the adequacy of the model, all results were confirmed with rolling mean blood glucose values calculated for up to 70 days prior to blood sampling for HbA lc assay.
Previous studies l 4-16 have demonstrated correlation coefficients of up to 0·99 between blood HbA 1c values and antecedent mean blood glucose concentrations. In this study, which was designed to pick up both peaks and troughs of glucose concentration, an overall correlation coefficient of 0·23 was obtained. The patients chosen to participate in the present study had a narrower range of mean blood glucose values (8-14mmoljL) , which was more representative of the clinical situation than previous studies. In general, a wider range of data will always tend to give higher correlation coefficients.!? Figure I shows graphically the large amount of scatter about the regression line. Based on these data, HbA 1c seemed to be a relatively poor indicator of previous mean blood glucose; in practical management terms, for a mean blood glucose of 10 mmol/L, one patient may have an HbA lc 74% higher than another. As other studies have concluded.P'!" it appears that there is too much variation in the population to allow for reliable calculation of previous mean blood glucose from the HbA 1c results.
In order to investigate the source of the high levels of variation about the HbA 1c versus mean blood glucose regression line, analysis of variation showed that, of the variables duration of diabetes, mean blood glucose and total haemoglobin, only the first of these had a statistically significant effect, HbA 1c levels tending to rise with increasing duration of diabetes. This finding has been reported previously in type I diabetic patients. 19 ,2o In addition, in a normal healthy Chinese population, an age-related increase in blood HhAj, has been noted.I' Although the mechanism is not clear, it is possible that increased oxidative stress may have some bearing on an increased susceptibility to non-enzymatic glycation. 22 ,23 As individual patients' HbA Ic values appeared to be set at different levels for similar blood glucose values (Fig. 2) , a glycation index was calculated as the ratio of the HbA lc to the mean blood glucose. This is an expression of the %HbA 1c for each mmol/L of blood glucose. The results showed significant differences between individuals (Fig. 3) . Previous studies 24 ,25 have classified normal individuals as high or low glycators by their HbA Ic levels relative to their response to a glucose tolerance test. It was found Patient number and replicate number were coded as nested factors to represent between-and within-patient effects. Total haemoglobin (Hb), mean blood glucose and duration of diabetes were entered as covariates. The columns represent effect and error degrees of freedom (d.f.) and mean squares (MS), together with their associated F statistics and P values. The results indicate the effect of the factors and covariates on the dependent variable, glycation index. In this case the covariates 'mean blood glucose' and 'duration of diabetes' and the factor 'patient number' showed significant effects. that there were differences between high and low glycators on the basis of their intra-erythrocyte 2,3-diphosphoglycerate and pH. It appears, therefore, that differences between individuals' glycation indices may be due to intracellular factors that may be more or less favourable to the glycation process. It is of particular interest in this study that in six of the ten patients there was an inverse relationship between glycation index and the mean blood glucose level. The implication of Ann cu« Biochem 1999: 36 this is that blood HbA 1c will be a less sensitive indicator of changes in blood glucose level at higher mean glucose levels. An earlier in vitro study has suggested that the glycation process is saturable", and another has shown a curvilinear relationship between HbA lc and mean blood glucose in type I diabetic patients." The patients in this latter study had mean blood concentrations ranging from 5 to over 20 mmol/L, The use of the glycation index in the present study has shown that the non-linear relationship between HbA\c and mean blood glucose may not just be a phenomenon of higher mean glucose values, but may also be influencing results in relatively well-controlled diabetic patients.
The key to these findings may lie in current research into the nature of the species identified as HbA 1c by cation-exchange chromatography using electrospray ionization mass spectrometry. It has been shown'" that glycated species that cochromatograph with HhA}, on cation-exchange columns include those with both glycated IX-and fJ-chains, non-glycated IX-and glycated fJ-chains and multiply glycated fJ-chains. In addition, it has been noted that, as glycation increases, the ratio of fJ-chain glycation to IX-chain glycation increases and the number of glycation sites on the p-chain increases. We therefore speculate that, as the mean blood glucose rises, conditions within the red cell would tend to favour the reaction between glucose and previously glycated haemoglobin, rather than with non-glycated haemoglobin.
In conclusion, we have confirmed that, in a diabetic population, significant differences exist between patients in their ability to glycate haemoglobin, and that there may not be a simple linear relationship between HbA le levels and previous mean blood glucose. We therefore recommend that patients be monitored on the basis of their own previous HbA le values, rather than by reference to population-derived ranges, and that clinicians should be aware that, in some patients, HbA le levels may become progressively less sensitive to change in previous mean blood glucose as these levels rise. Although a recently published method of measuring HbA le in clinical samples by mass spectrometry" may be unsuitable for routine use, it does show that more specific methods for the measurement of particular glycated species are technically within reach and may pave the way for the eventual development of more specific and sensitive tests.
